DE903817C - Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone - Google Patents

Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone

Info

Publication number
DE903817C
DE903817C DET11A DET0000011A DE903817C DE 903817 C DE903817 C DE 903817C DE T11 A DET11 A DE T11A DE T0000011 A DET0000011 A DE T0000011A DE 903817 C DE903817 C DE 903817C
Authority
DE
Germany
Prior art keywords
phenyl
amino
dimethyl
pyrazolone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DET11A
Other languages
German (de)
Inventor
Dr Johann Jonas
Dr Walter Schoeller
Dr Emil Tonutti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMIL TONUTTI DR
JOHANN JONAS DR
WALTER SCHOELLER DR
Original Assignee
EMIL TONUTTI DR
JOHANN JONAS DR
WALTER SCHOELLER DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMIL TONUTTI DR, JOHANN JONAS DR, WALTER SCHOELLER DR filed Critical EMIL TONUTTI DR
Priority to DET11A priority Critical patent/DE903817C/en
Application granted granted Critical
Publication of DE903817C publication Critical patent/DE903817C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/65031Five-membered rings having the nitrogen atoms in the positions 1 and 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung von Derivaten des 1-Phenyl-2, 3-dimethyl-4-amino-5-pyrazolons Bekanntlich läßt sich im i-Phenyl-2, 3ldimethylq.-a#m,ino-5-pyrazolon die antipyretisehe Wirkung durch Alkyl.ierung steigern.Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone It is known that in i-phenyl-2,3ldimethylq.-a # m, ino-5-pyrazolone the antipyretic Increase effect through alkylation.

Es wurde nun gefunden, daß man diese Steigerung noch übertreffen kann, wenn man in an sich bekannter Weise das i-Phenyl-2, 3-dimethyl-4-amino-5-pyrazolon in :die entsprechenden Diaralkyl- bzw. Dialkylphosphorsäureesterderivate überführt unter Herstellung einer N-P-Bindung. Die Herstellung der neuen Derivate des i-Phenyl-2, 3-dimethyl-d.-amino-5-pyrazolons erfolgt erfindungsgemäß dadurch, daß man auf i-Phenyl-2, 3-dimethyl-q.-amino-5-pyrazolon Monohalogenverbindungen von Dialkyl- bzw. Diaralkylphosphorsäureestern unter Neutralisation des gebildeten Halogenwasserstoffs einwirken läßt. Zur Neutralisation des Halogenwasserstoffs dienen vorzugsweise Alkaliacetate, wie Kaliumacetate in Methanol, oder tertiäre Basen, wie Pyridin oder T'riäthylamin. Auch ein zweites Äquivalent des i-Phenyl-2, 3-dimethyl-4.-amino-5-pyrazolons kann als Halogenw asserstoffacceptor verwendet werden. Der besondere Vorteil der neuen Verbindungen liegt darin, daß ihre Esternatur durch Verseifung die Ausscheidung und damit die Entgiftung ermöglicht im Gegen,s.atz zu den bisher verwendeten N-Di-alkyl-Derivaten.It has now been found that this increase can still be exceeded, if in a known manner the i-phenyl-2,3-dimethyl-4-amino-5-pyrazolone into: the corresponding diaralkyl or dialkyl phosphoric acid ester derivatives forming an N-P bond. The production of the new derivatives of i-phenyl-2, 3-dimethyl-d.-amino-5-pyrazolones is carried out according to the invention by using i-phenyl-2, 3-dimethyl-q.-amino-5-pyrazolone monohalogen compounds of dialkyl or diaralkyl phosphoric acid esters allowed to act with neutralization of the hydrogen halide formed. For neutralization of the hydrogen halide are preferably used alkali acetates, such as potassium acetates in Methanol or tertiary bases such as pyridine or triethylamine. Also a second Equivalent of i-phenyl-2, 3-dimethyl-4.-amino-5-pyrazolons can be used as halogen hydrogen acceptor be used. The particular advantage of the new compounds is that their ester nature enables excretion and thus detoxification through saponification in contrast, see sentence on the previously used N-di-alkyl derivatives.

Beispiel i io,i5 g i-Phenyl-2, 3-dimethyl-q.-amino-5-pyrazolon werden mit 7,25g Dimethylphosphorsäureesterchlorid in Anwesenheit einer Lösung von 8,2 g Natriumacetat und 2,8 g Ätzkali in Methanol umgesetzt. Nach beendeter Umsetzung beträgt das pH des Reaktionsgemisches 7,0 bis 7,2. Das gebildete Halogenalkalisalzgemisch wird entfernt und die Lösung eingeengt. Durch Animpfen kristallisiert der gebildete i - Phenyl - 2, 3 -dimethyl -4-am-ino-5-pyrazolon-N-phosphorsäured@imethylester aus. Die Reinigung erfolgt durch Umkristallisieren; das Produkt kristallisiert beispielsweise aus einem Aceton-Äther-Gemisch in farblosen Kristallen. welche nach sorgfältigem Trocknen den Schmelzpunkt 186 bis 187' besitzen. Die Verbindung ist sowohl in Wasser wie in den gebräuchlichen organischen Lösungsmitteln löslich.Example io, i5 g of i-phenyl-2,3-dimethyl-q.-amino-5-pyrazolone are reacted with 7.25 g of dimethylphosphoric acid ester chloride in the presence of a solution of 8.2 g of sodium acetate and 2.8 g of caustic potash in methanol. After the reaction has ended, the pH of the reaction mixture is 7.0 to 7.2. The resulting haloalkali salt mixture is removed and the solution is concentrated. The i-phenyl-2,3-dimethyl -4-am-ino-5-pyrazolone-N-phosphoric acid @ imethyl ester formed crystallizes out by seeding. The purification is carried out by recrystallization; the product crystallizes, for example, from an acetone-ether mixture in colorless crystals. which, after careful drying, have a melting point of 186 to 187 '. The compound is soluble in both water and common organic solvents.

Beispiel 2 1O,15 g i-Phenyl-2, 3-dimethyl-4-ami.no-5-pyrazolon werden in Acetonlösung mit 4,32 g Diäthylphosphorsäureesterchlorid umgesetzt. Das i-Phenyl-2, 3-.dimethyl-4-arriino-5-pyrazolonhydrochlorid kristallisiert aus und wird erbfiltriert. Die eingeengte Mutterlauge wird durch Animpfen zur Kristallisation gebracht.Example 2 10.15 g of i-phenyl-2, 3-dimethyl-4-ami.no-5-pyrazolone reacted in acetone solution with 4.32 g of diethylphosphoric acid ester chloride. The i-phenyl-2, 3-dimethyl-4-arriino-5-pyrazolone hydrochloride crystallizes out and is filtered off. The concentrated mother liquor is made to crystallize by inoculation.

Die farblose kristallisierte Verbindung von bitterem Geschmack zeigte einen Schmp. von 122°. Sie ist leicht löslich in Wasser, sehr leicht löslich auch in Alkoholen, Methylenchlorid, Chloroform, Aceton, Acetonitril und Dioxan. In Benzol, Essigester, Tetrahydrofuran und Tetrachlorkohlenstoff löst sie sich gut. Äther, Petroläther und Ligroin lösen praktisch nicht. Schwefelkohlenstoff löst sehr schwer.The colorless crystallized compound showed a bitter taste a melting point of 122 °. It is easily soluble in water, and also very easily soluble in alcohols, methylene chloride, chloroform, acetone, acetonitrile and dioxane. In benzene, It dissolves well in ethyl acetate, tetrahydrofuran and carbon tetrachloride. Ether, Petroleum ether and ligroin practically do not dissolve. Carbon disulfide is very difficult to dissolve.

In entsprechender Weise sind die Diisopropyl-, Di(n) hutyl-, Diisoamyl-, Dichloräthyl- .und Dihenzylphosphorsäüreesterderivate herstellbar.In a corresponding manner, the diisopropyl, di (n) hutyl, diisoamyl, Dichloroethyl and dihenzylphosphoric acid ester derivatives can be produced.

Das Dipropylderivat fällt in farblosen, glänzenden, stark verfilzten Nädelchen vom Schmp. i 16° an. Es ist in Wasser leicht löslich, ebenso in organischen Lösungsmitteln. Die Löslichkeit des Dipropylclerivats in Äther und Ligroin ist gegenüber dem Diäthvlderivat erhöht. Das Dibutvlderivat fällt zunächst in stark verfilzten Nädelchen aus, die sich beim Stehen zu derben, kurzen. Nädelchen umlagern und einen Schmp. von i i i bis 112° aufweisen. Das Dibutylderivat löst sich im Gegensatz zum Diäthyl- und Dipropylderiv at nur noch gering in Wasser, wohl aber in verdünnter Salzsäure, und bildet hierbei eine farblose Lösung. In organischen Lösungsmitteln ist das Dibutylderivat leicht löslich, Äther und Li.groin lösen Dias Dibutylderivat wesentlich leichter als das Diäthyl- und Dipropyliderivat.The dipropyl derivative falls in colorless, glossy, heavily matted Needles from the melting point i 16 °. It is easily soluble in water, as well as in organic ones Solvents. The solubility of the Dipropylclerivats in ether and ligroin is opposite the diethvlderivat increased. The dibutvl derivative initially falls into heavily matted Small needles that become coarse when standing, short. Move needles and one Have a melting point of i i i to 112 °. The dibutyl derivative dissolves in contrast to Diethyl and dipropyl derivative only slightly in water, but in more dilute form Hydrochloric acid, and forms a colorless solution. In organic solvents the dibutyl derivative is easily soluble, ether and Li.groin dissolve the dibutyl derivative much lighter than the diethyl and dipropylide derivatives.

Das Di-isoamylderivat kristallisiert in weißen, wachsartigen Nadeln vom Schmp. 89 bis 9i°. Es löst sich wenig in Wasser, hingegen in Methanol, Äthanol, Essigester, Äther, Chloroform, Benzol sowie in Essigsäure. In Petroläther ist es nicht löslich.The di-isoamyl derivative crystallizes in white, waxy needles with a melting point of 89 to 91 °. It dissolves little in water, but in methanol, ethanol, ethyl acetate, ether, chloroform, benzene and acetic acid. It is not soluble in petroleum ether.

Claims (3)

PATENTANSPRÜCHE: i. Verfahren zur Herstellung von Derivaten des i-Phenyl-2, 3-dimethyl-4-amino-5-pyrazolons, dadurch gekennzeichnet, daß man auf i-Phenyl-2, 3-dimethyl-4-amino-5-pyrazolon Momohalogenverbindungen von Dialkyl- bzw. Diaral,kylphosphors.äureestern unter Neutralisation des gebildeten Halogenwasserstoffs einwirken läßt. PATENT CLAIMS: i. Process for the preparation of derivatives of i-phenyl-2, 3-dimethyl-4-amino-5-pyrazolones, characterized in that i-phenyl-2, 3-dimethyl-4-amino-5-pyrazolone momohalogen compounds of dialkyl or diaral, kylphosphoric acid esters allowed to act with neutralization of the hydrogen halide formed. 2. Verfahren nach Anspruch i, dadurch gekennzeichnet, daß man zur Neutralisation Acetate .mitverwendet, zweckmäßig z. B. Kaliumacetat in methylalkoholischer Lösung. 2. Procedure according to claim i, characterized in that acetates are also used for neutralization, appropriate z. B. Potassium acetate in methyl alcoholic solution. 3. Verfahren nach Anspruch i, dadurch gekennzeichnet, -daß man zur Neutralisation ein zweites Äquivalent des i-Phenyl-2, 3-.d,imethyl-4-amino-5-pyrazolons verwendet. 4.. Verfahren nach Anspruch i, dadurch gekennzeichnet, daß als Kondensationsmittel tertiäre Basen, wie Pyrild:in oder Triäthylamin, verwendet werden.3. The method according to claim i, characterized in that a second equivalent of the i-Phenyl-2, 3-.d, imethyl-4-amino-5-pyrazolons are used. 4 .. Method according to claim i, characterized in that tertiary bases, such as Pyrild: in or triethylamine, can be used.
DET11A 1949-10-06 1949-10-06 Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone Expired DE903817C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DET11A DE903817C (en) 1949-10-06 1949-10-06 Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DET11A DE903817C (en) 1949-10-06 1949-10-06 Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone

Publications (1)

Publication Number Publication Date
DE903817C true DE903817C (en) 1954-02-11

Family

ID=7542824

Family Applications (1)

Application Number Title Priority Date Filing Date
DET11A Expired DE903817C (en) 1949-10-06 1949-10-06 Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone

Country Status (1)

Country Link
DE (1) DE903817C (en)

Similar Documents

Publication Publication Date Title
DE1795763A1 (en) PROCESS FOR THE PRODUCTION OF DESACYLATED NUCLEAR INDOLE COMPOUNDS AND THEIR ESTERS
DE2425983C3 (en) Sulphonic acid salts of acylcholines, processes for their preparation and pharmaceutical compositions containing them
DE1963645C3 (en) Process for the production of penicillins
DE903817C (en) Process for the preparation of derivatives of 1-phenyl-2,3-dimethyl-4-amino-5-pyrazolone
CH395967A (en) Process for the preparation of racemic and optically active 2,3-dimercaptosuccinic acid
DE1795413C3 (en) Process for the production of penicillin or penicillin sulfoxide esters
DE2058519A1 (en) Method for purifying ditrimethylolpropane
DE887816C (en) Process for the preparation of 1-nitrophenyl-2-aminopropane-1,3-diol derivatives
DE1960130A1 (en) New syntheses of n,n-(diethylaminoethyl)- - 4 amino 5 chloro 2 methoxybenzamide
DE825684C (en) Process for the production of carboxylic acid esters
DE2322053A1 (en) Prepn. of beta-blocking isopropylamines - using hydrogenation of a Schiff base in the presence of acetone
CH635057A5 (en) METHOD FOR PRODUCING TRICYCLOHEPTAN-6-ONES.
DE2637580C2 (en) METHOD FOR PRODUCING N-SUBSTITUTED OXAZOLIDINES
DE1645918B2 (en) PROCESS FOR THE PREPARATION OF THE SALICYL ACID ESTER OF BETA-PYRIDYLCARBINOL
AT326638B (en) PROCESS FOR THE PREPARATION OF N (BETA DIETYLAMINO ETHYL) -4-AMINO-5-CHLORO-2-METHOXYBENZAMIDE
DE940897C (en) Process for preparing the threo forms of oxazolines
DE2014801A1 (en) Process for the preparation of malononitrile derivatives
DE869959C (en) Process for the preparation of methyl derivatives of 4,5-diaminouracil or its acetyl compounds
DE878656C (en) Process for the preparation of haloacetamidodiols
AT212982B (en) Process for the separation of the optical antipodes of 3,5-diiodothyronine
DE957757C (en) Process for the selective production of N-mono- or N1O-diacyl derivatives of 1-p nitrophenyl-2amino-1,3-propanediols
DE3242433C2 (en)
AT375081B (en) METHOD FOR PRODUCING 7-AMINOCEPHALOSPORANIC ACID AND ITS ESTERS
DE1966212A1 (en) Metoclopramide prepn - from p-amino- salicylic acid
CH494241A (en) Thiol-type-thiamine derivs intermediates